Long-term safety and efficacy of rupatadine in Japanese patients with perennial allergic rhinitis: a 52-week open-label clinical trial

Objective: Long-term safety and efficacy of 10- and 20-mg rupatadine in Japanese patients with perennial allergic rhinitis (PAR) were investigated in a 52-week open-label study (JapicCTI-152952, clinicaltrials.jp). Methods: The rupatadine dose was fixed to 10 mg once daily for the first 2 weeks. The...

Descripción completa

Detalles Bibliográficos
Autores principales: Okubo, Kimihiro, Suzuki, Takamasa, Tanaka, Ayaka, Aoki, Hiroshi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Taylor & Francis 2019
Materias:
Allergy & Immunology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6567265/
https://www.ncbi.nlm.nih.gov/pubmed/31231589
http://dx.doi.org/10.1080/21556660.2019.1614005

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6567265/
https://www.ncbi.nlm.nih.gov/pubmed/31231589
http://dx.doi.org/10.1080/21556660.2019.1614005

Ejemplares similares